Corcept Therapeutics, Inc. (NASDAQ:CORT)

About the company

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

206

CEO

Joseph K. Belanoff

Exchange

NASDAQ

Website

http://www.corcept.com

$335.00M

Total Revenue

206

Employees

$2B

Market Capitalization

19.64

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$329M

Operating Margin (in %)

Total operating margin

$130M

Net Margin (in %)

Total net margin

$106M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11671.80 1376.00 4.98 18.40 43.06
Catalent, Inc. CTLT 10932.13 2872.00 5.49 104.81 3.63
Perrigo Co. Plc PRGO 7571.99 4837.00 1.30 51.65 3.02
Bausch Health Cos., Inc. BHC 6456.37 8597.00 9.01 -3.41 -21.96
Jazz Pharmaceuticals Plc JAZZ 6247.77 2188.00 2.16 22.84 12.81
United Therapeutics Corp. UTHR 5203.00 1443.00 1.81 10.04 36.59
MyoKardia, Inc. MYOK 4444.52 34.00 12.92 -14.34 -201.73
Axsome Therapeutics, Inc. AXSM 2672.60 None 18.14 -29.71 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Pacira Biosciences, Inc. PCRX 2231.88 435.00 5.98 -5314.00 -0.02
SAGE Therapeutics, Inc. SAGE 2162.16 9.00 2.54 -3.34 -413.06
Corcept Therapeutics, Inc. CORT 2084.98 335.00 4.79 19.64 31.64
Revolution Medicines, Inc. RVMD 1920.45 48.00 4.98 -27.12 -146.29
Prestige Consumer Healthcare, Inc. PBH 1881.39 963.00 1.58 13.27 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1765.35 0.00 4.71 -17.28 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1620.24 440.00 -22.93 19.11 19.14
Innoviva, Inc. INVA 1574.09 285.00 3.72 8.15 66.41
Intercept Pharmaceuticals, Inc. ICPT 1476.16 272.00 -43.93 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1308.15 5.00 3.57 -3.08 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1254.96 402.00 1.99 10.76 28.90
Theravance Biopharma, Inc. TBPH 1196.43 88.00 -8.40 -4.85 -280.80
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Amphastar Pharmaceuticals, Inc. AMPH 1100.54 327.00 2.75 21.60 15.90
Endo International Plc ENDP 800.28 3014.00 -1.09 -2.85 -9.09
BellRing Brands, Inc. BRBR 764.79 954.00 -0.41 5.80 13.98
Aerie Pharmaceuticals, Inc. AERI 678.96 79.00 5.39 -3.35 -252.92
Assembly Biosciences, Inc. ASMB 676.28 16.00 3.03 -6.80 -601.75
Eagle Pharmaceuticals, Inc. EGRX 671.72 192.00 3.61 266.56 1.29
Collegium Pharmaceutical, Inc. COLL 590.58 299.00 4.23 -45.71 -4.21
Anika Therapeutics, Inc. ANIK 539.98 125.00 1.87 19.48 22.73
Catalyst Pharmaceuticals, Inc. CPRX 487.92 119.00 4.75 11.12 36.09
Intersect ENT, Inc. XENT 411.20 102.00 3.88 -8.24 -48.61
BioDelivery Sciences International, Inc. BDSI 405.26 130.00 5.80 -55.06 -5.01
ANI Pharmaceuticals, Inc. ANIP 391.32 203.00 2.00 -250.85 -0.67
MEI Pharma, Inc. MEIP 356.90 5.00 6.14 -9.15 -539.48
Albireo Pharma, Inc. ALBO 344.37 11.00 3.50 -4.51 -730.55
Mallinckrodt Plc MNK 233.52 3037.00 0.12 -0.19 -39.56
Marinus Pharmaceuticals, Inc. MRNS 168.21 0.00 6.51 -2.50 None
Agile Therapeutics, Inc. AGRX 164.02 None 2.67 -7.94 None
Zynerba Pharmaceuticals, Inc. ZYNE 144.90 0.00 2.38 -4.04 -699.94
Cerecor, Inc. CERC 119.60 7.00 7.65 -5.31 -429.22
Ampio Pharmaceuticals, Inc. AMPE 97.81 1.00 68.40 -5.26 None
AcelRx Pharmaceuticals, Inc. ACRX 94.40 2.00 -1.74 -1.69 -644.25
Evoke Pharma, Inc. EVOK 84.96 None 29.50 -12.64 None
Adamas Pharmaceuticals, Inc. ADMS 70.28 57.00 -4.48 -0.76 -160.44
CTI BioPharma Corp. CTIC 68.44 3.00 3.05 -1.66 -111.83
Aclaris Therapeutics, Inc. ACRS 66.42 4.00 1.17 -0.48 None
Oramed Pharmaceuticals, Inc. ORMP 63.54 3.00 5.12 -4.97 -464.15
Cassava Sciences, Inc. SAVA 56.81 41.00 2.99 -12.46 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.95 47.00 1.02 -11.10 -9.59
SCYNEXIS, Inc. SCYX 49.93 0.00 10.49 -1.29 -30.84
Natural Alternatives International, Inc. NAII 48.37 114.00 0.66 -12.80 -3.19
Lipocine, Inc. LPCN 37.80 0.00 9.00 -2.52 None
IsoRay, Inc. ISR 37.77 9.00 7.05 -11.27 -36.08
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.25 65.00 -2.63 -1.96 -26.74
PLx Pharma, Inc. PLXP 27.99 0.00 -2.68 -2.96 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.61 3.00 2.44 -1.66 -264.21
Regulus Therapeutics, Inc. RGLS 14.91 0.00 1.31 -0.70 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.60 8.00 0.67 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.87 None 1.40 -0.25 None
VIVUS, Inc. VVUS 9.02 73.00 -0.20 -0.30 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 7.12 19.00 1.13 -2.28 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.42 None 1.69 -0.46 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.36 None 1.09 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Standing By Corcept Therapeutics Incorporated (CORT)

12d ago, source: YAHOO!

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive ...

Corcept Therapeutics Inc.

13d ago, source: MarketWatch

02/14/2020 N/A SC 13G/A Institutional Ownership * 02/14/2020 N/A SC 13G/A Institutional Ownership * 02/12/2020 N/A SC 13G Institutional Ownership 02/12/2020 N/A SC ...

Corcept Therapeutics initiates late-study for Relacorilant doublet therapy in pancreatic cancer

14h ago, source: Seeking Alpha

Corcept Therapeutics (CORT +1.2%) enrolls first patient in RELIANT, a Phase 3 trial of relacorilant in combination with nab-paclitaxel (Celgene’s Abraxane) in patients with metastatic pancreatic cance ...

Financials Corcept Therapeutics

12d ago, source: Business Insider

© 2020 Insider Inc. and finanzen.net GmbH All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy ...

Corcept launches late-stage study of relacorilant in pancreatic cancer

14h ago, source: Seeking Alpha

Corcept Therapeutics (CORT +1.2%) enrolls first patient in RELIANT, a Phase 3 trial of relacorilant in combination with nab-paclitaxel (Celgene’s Abraxane) in patients with metastatic pancreatic cance ...

First Week of CORT February 2021 Options Trading

9d ago, source: Nasdaq

Investors in Corcept Therapeutics Inc (Symbol: CORT) saw new options begin trading this week, for the February 2021 ...

Engineers Gate Manager LP Sells 89,838 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)

4d ago, source: modernreaders.com

Engineers Gate Manager LP trimmed its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) by 63.7% during ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.